Dossett LA, Harrington M, Cruse CW, Gonzalez RJ. Cutaneous angiosarcoma. Curr Probl Cancer. 2015;39:258–63.

Article  PubMed  Google Scholar 

Young RJ, Brown NJ, Reed MW, Hughes D, Woll PJ. Angiosarcoma. Lancet Oncol. 2010;11:983–91.

Article  PubMed  Google Scholar 

Espejo-Freire AP, Elliott A, Rosenberg A, Costa PA, Barreto-Coelho P, Jonczak E, et al. Genomic landscape of angiosarcoma: a targeted and immunotherapy biomarker analysis. Cancers (Basel). 2021;13:4816.

Ramakrishnan N, Mokhtari R, Charville GW, Bui N, Ganjoo K. Cutaneous angiosarcoma of the head and neck-A retrospective analysis of 47 patients. Cancers (Basel). 2022;14:3841.

Hata M. Radiation therapy for angiosarcoma of the scalp: total scalp irradiation and local irradiation. Anticancer Res. 2018;38:1247–53.

PubMed  Google Scholar 

Penel N, Bui BN, Bay JO, Cupissol D, Ray-Coquard I, Piperno-Neumann S, et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol. 2008;26:5269–74.

Article  CAS  PubMed  Google Scholar 

Heinhuis, KM, NS, IJ, van der Graaf, WTA, Kerst, JM, Schrage, Y, et al. Neoadjuvant systemic treatment of primary angiosarcoma. Cancers (Basel). 12 (2020).

Wilmas KM, Garner WB, Ballo MT, McGovern SL, MacFarlane DF. The role of radiation therapy in the management of cutaneous malignancies. Part II: When is radiation therapy indicated? J Am Acad Dermatol. 2021;85:551–62.

Article  PubMed  Google Scholar 

Ravi V, Subramaniam A, Zheng J, Amini B, Trinh VA, Joseph J, et al. Clinical activity of checkpoint inhibitors in angiosarcoma: a retrospective cohort study. Cancer. 2022;128:3383–91.

Article  CAS  PubMed  Google Scholar 

Shin JY, Roh SG, Lee NH, Yang KM. Predisposing factors for poor prognosis of angiosarcoma of the scalp and face: systematic review and meta-analysis. Head Neck. 2017;39:380–6.

Article  PubMed  Google Scholar 

Hoshina D, Abe R, Yoshioka N, Saito N, Hata H, Fujita Y, et al. Establishment of a novel experimental model of human angiosarcoma and a VEGF-targeting therapeutic experiment. J Dermatol Sci. 2013;70:116–22.

Article  CAS  PubMed  Google Scholar 

Ito T, Kohashi K, Yamada Y, Iwasaki T, Maekawa A, Kuda M, et al. Prognostic significance of forkhead box M1 (FOXM1) expression and antitumor effect of FOXM1 inhibition in angiosarcoma. J Cancer. 2016;7:823–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sacchetti L, Calcagno G, Coto I, Tinto N, Vuttariello E, Salvatore F. Efficiency of two different nine-loci short tandem repeat systems for DNA typing purposes. Clin Chem. 1999;45:178–83.

Article  CAS  PubMed  Google Scholar 

Yanagi T, Reed JC, Matsuzawa S. PCTAIRE1 regulates p27 stability, apoptosis and tumor growth in malignant melanoma. Oncoscience. 2014;1:624–33.

Article  PubMed  PubMed Central  Google Scholar 

Hsu CY, Yanagi T, Maeda T, Nishihara H, Miyamoto K, Kitamura S, et al. Eribulin inhibits growth of cutaneous squamous cell carcinoma cell lines and a novel patient-derived xenograft. Sci Rep. 2023;13:8650.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sullivan HC, Edgar MA, Cohen C, Kovach CK, HooKim K, Reid MD. The utility of ERG, CD31 and CD34 in the cytological diagnosis of angiosarcoma: an analysis of 25 cases. J Clin Pathol. 2015;68:44–50.

Article  PubMed  Google Scholar 

Zheng P, Zhou C, Lu L, Liu B, Ding Y. Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy. J Exp Clin Cancer Res. 2022;41:271.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cirkel GA, Kerklaan BM, Vanhoutte F, Van der Aa A, Lorenzon G, Namour F, et al. A dose escalating phase I study of GLPG0187, a broad spectrum integrin receptor antagonist, in adult patients with progressive high-grade glioma and other advanced solid malignancies. Invest N Drugs. 2016;34:184–92.

Article  CAS  Google Scholar 

van der Horst G, van den Hoogen C, Buijs JT, Cheung H, Bloys H, Pelger RC, et al. Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer. Neoplasia. 2011;13:516–25.

Article  PubMed  PubMed Central  Google Scholar 

Sogbein O, Paul P, Umar M, Chaari A, Batuman V, Upadhyay R. Bortezomib in cancer therapy: mechanisms, side effects, and future proteasome inhibitors. Life Sci. 2024;358:123125.

Article  CAS  PubMed  Google Scholar 

Kubiczkova L, Pour L, Sedlarikova L, Hajek R, Sevcikova S. Proteasome inhibitors - molecular basis and current perspectives in multiple myeloma. J Cell Mol Med. 2014;18:947–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fricker LD. Proteasome inhibitor drugs. Annu Rev Pharm Toxicol. 2020;60:457–76.

Article  CAS  Google Scholar 

Hideshima T, Ikeda H, Chauhan D, Okawa Y, Raje N, Podar K, et al. Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cells. Blood. 2009;114:1046–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Annunziata CM, Davis RE, Demchenko Y, Bellamy W, Gabrea A, Zhan F, et al. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell. 2007;12:115–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Keats JJ, Fonseca R, Chesi M, Schop R, Baker A, Chng WJ, et al. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell. 2007;12:131–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Obeng EA, Carlson LM, Gutman DM, Harrington WJ Jr., Lee KP, Boise LH. Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood. 2006;107:4907–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oakes SA, Papa FR. The role of endoplasmic reticulum stress in human pathology. Annu Rev Pathol. 2015;10:173–94.

Article  CAS  PubMed  Google Scholar 

Rozpedek W, Pytel D, Mucha B, Leszczynska H, Diehl JA, Majsterek I. The role of the PERK/eIF2α/ATF4/CHOP signaling pathway in tumor progression during endoplasmic reticulum stress. Curr Mol Med. 2016;16:533–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Groenendyk J, Michalak M. Endoplasmic reticulum quality control and apoptosis. Acta Biochim Pol. 2005;52:381–95.

Article  CAS  PubMed  Google Scholar 

Li J, Lee AS. Stress induction of GRP78/BiP and its role in cancer. Curr Mol Med. 2006;6:45–54.

Article  CAS  PubMed  Google Scholar 

Ye ZW, Zhang J, Aslam M, Blumental-Perry A, Tew KD, Townsend DM. Protein disulfide isomerase family mediated redox regulation in cancer. Adv Cancer Res. 2023;160:83–106.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Guo Y, Tang J, Jiang J, Chen Z. New insights into the roles of CHOP-induced apoptosis in ER stress. Acta Biochim Biophys Sin (Shanghai). 2014;46:629–40.

Article  CAS  PubMed  Google Scholar 

Adams J. The proteasome: a suitable antineoplastic target. Nat Rev Cancer. 2004;4:349–60.

Article  CAS  PubMed  Google Scholar 

Cheah CY, Seymour JF, Wang ML. Mantle cell lymphoma. J Clin Oncol. 2016;34:1256–69.